-
Diagnostics World | A private biomedical engineering and biomarker research lab in Canada has succeeded in measuring what type 2 diabetes does to the body as manifested through the voice and it is “opening a new lens” to the identification of at-risk individuals and potentially the assessment of therapeutic interventions.
Nov 2, 2023
-
Diagnostics World | Researchers at the University of Western Ontario and Brown University were surprised to discover an “almost identical mechanism” appearing in the blood and placenta of women with preeclampsia as has been previously found in the brains of older individuals with Alzheimer’s disease (AD), traumatic brain injury (TBI), and vascular dementia.
Nov 1, 2023
-
Diagnostics World | Researchers at Dana-Farber Cancer Institute and Massachusetts Institute of Technology have developed a new tool, based on artificial intelligence, that predicts the likely site of formation for cancer of unknown primary (CUP) tumors.
Oct 31, 2023
-
Diagnostics World | Mayo Clinic and Oxford Nanopore Technologies teams up in a multi-year joint development collaboration to help improve patient care, including some of the hardest-to-characterize conditions and sequencing DNA; Walgreens and the Cardiovascular Research Foundation (CRF) collaborates to drive the PREVUE-VALVE study, which will help pave the way for the development of new therapies and tools for VHD detection and diagnosis; Genialis announces a new data-sharing collaboration with Cancer Research Horizons to better predict responses to KRAS inhibitors, immunotherapies, and other emerging classes of therapeutics; and more.
Oct 26, 2023
-
Diagnostics World | bioMérieux further invests in Oxford Nanopore to expand in vitro diagnostics production; Harbinger Health trials blood-based cancer screening platform; HHS funds behavioral health services and HIV prevention for underserved populations; and more.
Oct 25, 2023